Suplatast tosilate

Drug Profile

Suplatast tosilate

Alternative Names: IPD; IPD 1151T; Suplatast tosylate; YM 672

Latest Information Update: 20 May 2017

Price : $50

At a glance

  • Originator Taiho Pharmaceutical
  • Developer Senju Pharmaceutical; Taiho Pharmaceutical
  • Class Antiallergics; Antiasthmatics; Antihistamines; Arylsulfonates
  • Mechanism of Action Cytokine inhibitors; Histamine release inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma; Atopic dermatitis
  • No development reported Prostatitis; Pulmonary eosinophilia
  • Discontinued Interstitial cystitis

Most Recent Events

  • 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in Europe (PO)
  • 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in USA (PO)
  • 06 Nov 2007 Discontinued - Phase-III for Interstitial cystitis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top